DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 70 filers reported holding DICE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $102,181,429 | -9.7% | 2,199,342 | -44.3% | 1.39% | -17.4% |
| Q1 2023 | $113,167,500 | +43.6% | 3,950,000 | +56.4% | 1.68% | +42.4% |
| Q4 2022 | $78,797,316 | +261.4% | 2,525,555 | +134.9% | 1.18% | +192.3% |
| Q3 2022 | $21,801,000 | +30.7% | 1,075,000 | 0.0% | 0.40% | +22.1% |
| Q2 2022 | $16,684,000 | -18.9% | 1,075,000 | 0.0% | 0.33% | -12.0% |
| Q1 2022 | $20,565,000 | +44.4% | 1,075,000 | +91.1% | 0.38% | +55.0% |
| Q4 2021 | $14,237,000 | -45.7% | 562,500 | -29.7% | 0.24% | -41.3% |
| Q3 2021 | $26,200,000 | – | 800,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
| Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
| OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
| Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
| Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
| RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
| Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
| Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
| HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |